Prospective Evaluation of Ruxolitinib Efficacy for CNL/aCML Patients with Mutation of CSF3R
The goal of this research study is to learn about the effects, good and/or bad, ruxolitinib has on patients with CNL or aCML. The safety of this drug will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 05/05/2015
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: